STADA appoints Mark Pearson as Head and EVP, Global Consumer Healthcare
pharmafile | July 20, 2026 | Appointment | | Stada
STADA has appointed former Reckitt executive Mark Pearson as Head and Executive Vice-President (EVP), Global Consumer Healthcare. Pearson, who also joins the STADA Executive Committee, will be based in Bad Vilbel, Germany, and will report directly to CEO Peter Goldschmidt.
Pearson brings 25 years of international consumer healthcare experience, having held senior operational and global leadership roles at Reckitt across the UK, Brazil, Russia, Poland and North America. Most recently, he led Reckitt’s global Vitamins, Minerals & Supplements business and contributed significantly to the company’s strategic transformation in North America.
Goldschmidt commented: “Mark’s experience, leadership style and commitment to growth make him an excellent fit for STADA. I am confident that Mark will help accelerate the development and support the long-term advancement of the strategy of our Global Consumer Healthcare business as an important growth driver for STADA.”
Commenting on his appointment, Pearson stated: “What excites me most about joining STADA is its growth culture. Consumer expectations in health and wellness are accelerating every year, and the companies that will lead this decade are the ones that, through their culture, grow and adapt at the speed consumers need.”
“By delivering solutions and innovations with greater simplicity, relevance, and speed, we will reach more consumers, and thereby make life better for more people across our extensive commercial footprint throughout Europe and our fast-growing CHC presence in Asia.”
Related Content
STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases
STADA and Bio-Thera’s Gotenfia (golimumab), a biosimilar of Janssen’s Simponi, has received a positive opinion …
Takeda to jettison non-core asset portfolio to Stada for $660 million
Takeda has announced it is divesting a portfolio of its over-the-counter (OTC) and prescription drug …
Stada takeover back in motion after revised bid
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a …
